These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12377578)

  • 21. Lack of BDNF expression through promoter IV disturbs expression of monoamine genes in the frontal cortex and hippocampus.
    Sakata K; Duke SM
    Neuroscience; 2014 Feb; 260():265-75. PubMed ID: 24345476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Similar properties of fetal and adult amine transporters in the rat brain.
    Hyde CE; Bennett BA
    Brain Res; 1994 May; 646(1):118-23. PubMed ID: 8055328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action.
    Fon EA; Pothos EN; Sun BC; Killeen N; Sulzer D; Edwards RH
    Neuron; 1997 Dec; 19(6):1271-83. PubMed ID: 9427250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurochemical characterization of the release and uptake of dopamine in ventral tegmental area and serotonin in substantia nigra of the mouse.
    John CE; Budygin EA; Mateo Y; Jones SR
    J Neurochem; 2006 Jan; 96(1):267-82. PubMed ID: 16300629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-activity relationships at monoamine transporters and muscarinic receptors for N-substituted-3alpha-(3'-chloro-, 4'-chloro-, and 4',4''-dichloro-substituted-diphenyl)methoxytropanes.
    Newman AH; Robarge MJ; Howard IM; Wittkopp SL; George C; Kopajtic T; Izenwasser S; Katz JL
    J Med Chem; 2001 Feb; 44(4):633-40. PubMed ID: 11170654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoamine transporters and psychostimulant drugs.
    Rothman RB; Baumann MH
    Eur J Pharmacol; 2003 Oct; 479(1-3):23-40. PubMed ID: 14612135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predominant role of plasma membrane monoamine transporters in monoamine transport in 1321N1, a human astrocytoma-derived cell line.
    Naganuma F; Yoshikawa T; Nakamura T; Iida T; Harada R; Mohsen AS; Miura Y; Yanai K
    J Neurochem; 2014 May; 129(4):591-601. PubMed ID: 24471494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An affinity-modulating site on neuronal monoamine transport proteins.
    Plenge P; Mellerup ET
    Pharmacol Toxicol; 1997 Apr; 80(4):197-201. PubMed ID: 9140140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localization of norepinephrine and serotonin transporter in mouse brain capillary endothelial cells.
    Wakayama K; Ohtsuki S; Takanaga H; Hosoya K; Terasaki T
    Neurosci Res; 2002 Oct; 44(2):173-80. PubMed ID: 12354632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference.
    Sora I; Hall FS; Andrews AM; Itokawa M; Li XF; Wei HB; Wichems C; Lesch KP; Murphy DL; Uhl GR
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5300-5. PubMed ID: 11320258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.
    Rickli A; Moning OD; Hoener MC; Liechti ME
    Eur Neuropsychopharmacol; 2016 Aug; 26(8):1327-37. PubMed ID: 27216487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depression and antidepressants: insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters.
    Haenisch B; Bönisch H
    Pharmacol Ther; 2011 Mar; 129(3):352-68. PubMed ID: 21147164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression cloning of a serotonin transporter: a new way to study antidepressant drugs.
    Hoffman BJ
    Pharmacopsychiatry; 1994 Jan; 27(1):16-22. PubMed ID: 8159777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function.
    Fleckenstein AE; Haughey HM; Metzger RR; Kokoshka JM; Riddle EL; Hanson JE; Gibb JW; Hanson GR
    Eur J Pharmacol; 1999 Oct; 382(1):45-9. PubMed ID: 10556503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo microdialysis for measurement of extracellular monoamine levels following inhibition of monoamine transporters.
    Chen NH; Reith ME
    Methods Enzymol; 1998; 296():719-30. PubMed ID: 9779485
    [No Abstract]   [Full Text] [Related]  

  • 36. Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions.
    Hall FS; Li XF; Sora I; Xu F; Caron M; Lesch KP; Murphy DL; Uhl GR
    Neuroscience; 2002; 115(1):153-61. PubMed ID: 12401330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of psychotropic substances on the deamination of monoamines in the rat brain].
    Gol'dina OA; Gankina EM
    Farmakol Toksikol; 1988; 51(4):22-5. PubMed ID: 3191966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ancestry of neuronal monoamine transporters in the Metazoa.
    Caveney S; Cladman W; Verellen L; Donly C
    J Exp Biol; 2006 Dec; 209(Pt 24):4858-68. PubMed ID: 17142674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uptake of the neurotoxin, 4-methylphenylpyridinium, into chromaffin granules and synaptic vesicles: a proton gradient drives its uptake through monoamine transporter.
    Moriyama Y; Amakatsu K; Futai M
    Arch Biochem Biophys; 1993 Sep; 305(2):271-7. PubMed ID: 8373164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of the anorectic medication, phendimetrazine, and its metabolites with monoamine transporters in rat brain.
    Rothman RB; Katsnelson M; Vu N; Partilla JS; Dersch CM; Blough BE; Baumann MH
    Eur J Pharmacol; 2002 Jun; 447(1):51-7. PubMed ID: 12106802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.